Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Use of efaproxiral in brain metastases from breast cancer improved survival
February 9th, 2006
Use of efaproxiral as a radiation enhancer in brain metastases from breast cancer improved patient survival. According to an article published in the journal Annals of Pharmacotherapy, scientists in the United States conducted a study "to review the mechanism of action and clinical data of efaproxiral use in brain metastases of breast cancer. Articles were identified through MEDLINE (1966-June 2005) and EMBASE (1980-May 2005) searches using the keywords efaproxiral and RSR13." "Published abstracts over the previous 10 years from various scientific meetings, including American Society of Clinical Oncology and San Antonio Breast Cancer...
Source: Women's Health Weekly (2006-02-09)
|
